ATE218342T1 - Verwendung von rifaximin als medikament zur behandlung von durch cryptosporidiose verursachten diarrhoeen - Google Patents
Verwendung von rifaximin als medikament zur behandlung von durch cryptosporidiose verursachten diarrhoeenInfo
- Publication number
- ATE218342T1 ATE218342T1 AT98101081T AT98101081T ATE218342T1 AT E218342 T1 ATE218342 T1 AT E218342T1 AT 98101081 T AT98101081 T AT 98101081T AT 98101081 T AT98101081 T AT 98101081T AT E218342 T1 ATE218342 T1 AT E218342T1
- Authority
- AT
- Austria
- Prior art keywords
- cryptosporidiosis
- rifaximin
- treatment
- medication
- diarrhea caused
- Prior art date
Links
- 208000008953 Cryptosporidiosis Diseases 0.000 title abstract 2
- 206010011502 Cryptosporidiosis infection Diseases 0.000 title abstract 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title abstract 2
- 229960003040 rifaximin Drugs 0.000 title abstract 2
- 206010012735 Diarrhoea Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97BO000064A IT1290679B1 (it) | 1997-02-14 | 1997-02-14 | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE218342T1 true ATE218342T1 (de) | 2002-06-15 |
Family
ID=11341939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98101081T ATE218342T1 (de) | 1997-02-14 | 1998-01-22 | Verwendung von rifaximin als medikament zur behandlung von durch cryptosporidiose verursachten diarrhoeen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5886002A (de) |
| EP (1) | EP0858804B1 (de) |
| JP (1) | JP4848083B2 (de) |
| KR (1) | KR100436243B1 (de) |
| CN (1) | CN1115146C (de) |
| AT (1) | ATE218342T1 (de) |
| DE (1) | DE69805672T2 (de) |
| DK (1) | DK0858804T3 (de) |
| ES (1) | ES2178048T3 (de) |
| HU (1) | HU224592B1 (de) |
| IT (1) | IT1290679B1 (de) |
| PT (1) | PT858804E (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| WO2004099168A2 (en) * | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Substituted carboxylic acids |
| US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
| US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
| US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
| SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| JP5844961B2 (ja) * | 2006-08-02 | 2016-01-20 | サリックス ファーマシューティカルズ， インコーポレイテッド | 放射線直腸ｓ状結腸炎を処置するための組成物および方法 |
| US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
| US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
| DK2327407T3 (da) * | 2008-09-26 | 2014-08-25 | Aska Pharm Co Ltd | Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme |
| US12285414B2 (en) | 2008-10-02 | 2025-04-29 | Salix Pharmaceuticals, Inc. | Methods of treating hepatic encephalopathy |
| SMT202400116T1 (it) | 2008-10-02 | 2024-05-14 | Salix Pharmaceuticals Ltd | Trattamento dell’encefalopatia epatica utilizzando rifaximina |
| US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| RU2012126084A (ru) | 2009-11-23 | 2013-12-27 | Сипла Лимитед | Пенная композиция для местного применения |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| EP2544660B1 (de) * | 2010-03-10 | 2018-06-13 | Lupin Limited | Gebrauchsfertige rifaximinsuspension |
| CN103221032A (zh) | 2010-09-13 | 2013-07-24 | 西普拉有限公司 | 药物组合物 |
| WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
| PT3546464T (pt) | 2014-05-12 | 2020-08-05 | Alfasigma Spa | Preparação e utilização da forma cristalina tau de rifaximina solvatada com degme |
| CN106999477B (zh) * | 2014-06-30 | 2020-04-10 | 萨利克斯药品公司 | 用于重复治疗肠易激综合征(ibs)的方法 |
| US20180021297A1 (en) * | 2015-02-26 | 2018-01-25 | Jaguar Health, Inc. | Use Of Croton- Or Calophyllum-Derived Proanthocyanidin Polymers Or Botanical Extracts In Combination With Rifaximin For The Treatment Of Diarrhea In Non-Human Animals |
| JP6817966B2 (ja) * | 2015-06-10 | 2021-01-20 | シンロジック オペレーティング カンパニー インコーポレイテッド | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
| EP3525825B1 (de) | 2016-10-14 | 2024-03-20 | Cipla Limited | Pharmazeutische zusammensetzungen mit rifaximin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264494B1 (it) * | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
-
1997
- 1997-02-14 IT IT97BO000064A patent/IT1290679B1/it active IP Right Grant
-
1998
- 1998-01-22 PT PT98101081T patent/PT858804E/pt unknown
- 1998-01-22 EP EP98101081A patent/EP0858804B1/de not_active Expired - Lifetime
- 1998-01-22 ES ES98101081T patent/ES2178048T3/es not_active Expired - Lifetime
- 1998-01-22 DE DE69805672T patent/DE69805672T2/de not_active Expired - Lifetime
- 1998-01-22 HU HU9800115A patent/HU224592B1/hu active IP Right Grant
- 1998-01-22 DK DK98101081T patent/DK0858804T3/da active
- 1998-01-22 AT AT98101081T patent/ATE218342T1/de active
- 1998-01-26 US US09/013,655 patent/US5886002A/en not_active Expired - Lifetime
- 1998-02-12 JP JP02981398A patent/JP4848083B2/ja not_active Expired - Lifetime
- 1998-02-13 KR KR10-1998-0004389A patent/KR100436243B1/ko not_active Expired - Lifetime
- 1998-02-13 CN CN98106920A patent/CN1115146C/zh not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR100436243B1 (ko) | 2004-08-25 |
| HU224592B1 (hu) | 2005-11-28 |
| EP0858804B1 (de) | 2002-06-05 |
| ITBO970064A0 (it) | 1997-02-14 |
| HUP9800115A3 (en) | 2000-04-28 |
| ITBO970064A1 (it) | 1998-08-14 |
| HU9800115D0 (en) | 1998-03-30 |
| DE69805672D1 (de) | 2002-07-11 |
| PT858804E (pt) | 2002-10-31 |
| ES2178048T3 (es) | 2002-12-16 |
| US5886002A (en) | 1999-03-23 |
| JPH10226645A (ja) | 1998-08-25 |
| CN1214244A (zh) | 1999-04-21 |
| DE69805672T2 (de) | 2003-01-23 |
| HUP9800115A1 (hu) | 1999-06-28 |
| JP4848083B2 (ja) | 2011-12-28 |
| KR19980071348A (ko) | 1998-10-26 |
| IT1290679B1 (it) | 1998-12-10 |
| CN1115146C (zh) | 2003-07-23 |
| EP0858804A1 (de) | 1998-08-19 |
| DK0858804T3 (da) | 2002-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69805672D1 (de) | Verwendung von Rifaximin als Medikament zur Behandlung von durch Cryptosporidiose verursachten Diarrhoeen | |
| DE69635959D1 (de) | Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme | |
| ATE212345T1 (de) | Heterocyclische verbindungen und ihre herstellung und verwendung | |
| ATE339968T1 (de) | Verwendung von mglur5 antagonists zur herstellung von medikamenten zur behandlung von empfindlichen x syndrome, autismus und geistiger zurückgebliebenheit | |
| DE60237635D1 (de) | Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose | |
| MA27113A1 (fr) | Activateurs de glucokinase oxygenes cycloalkyle ou substitues cycloalkyle | |
| MY131458A (en) | Pyrolopyrimidine compounds | |
| BG104599A (en) | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas | |
| TR199902538T2 (xx) | Yeni bile�imler. | |
| TR200101567T2 (tr) | Yeni triazolo(4.5-D)pirimidin bileşimleri. | |
| TR200001203T2 (tr) | Yeni birleşik maddeler | |
| IL110031A0 (en) | Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them | |
| DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
| BR0014381A (pt) | Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência | |
| TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
| ATE235244T1 (de) | Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten | |
| IL104261A0 (en) | Azacyclic and azabicyclic compounds,their preparation and pharmaceutical compositions containing them | |
| DE69814135D1 (de) | 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel | |
| BR0111989A (pt) | Peptìdeos, composições e processos para o tratamento de burkholderia cepacia | |
| NO994330D0 (no) | Metode for behandling av en tumor | |
| TR200000907T2 (tr) | Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. | |
| ATE199321T1 (de) | Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. | |
| DE69830450D1 (de) | Neue Atropisomere von 2,3-Disubstituierten-(5,6)-heteroarylkondensierten-pyrimidin-4-onen | |
| ATE212548T1 (de) | Behandlung und prophylaxe von pankreatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |